Comparison of the Fenwal Amicus and Fresenius Com.Tec cell separators for autologous peripheral blood progenitor cell collection

被引:8
|
作者
Altuntas, Fevzi [1 ]
Kocyigit, Ismail
Ozturk, Ahmet
Kaynar, Leylagul
Sari, Ismail
Oztekin, Mehmet
Solmaz, Musa
Eser, Bulent
Cetin, Mustafa
Unal, Ali
机构
[1] Erciyes Med Sch, Dept Hematol, TR-38039 Kayseri, Turkey
[2] Erciyes Med Sch, Apheresis Unit, TR-38039 Kayseri, Turkey
[3] Erciyes Med Sch, Dept Biostat, Kayseri, Turkey
[4] Pamukkale Med Sch, Dept Hematol, Denizli, Turkey
[5] Apheresis Unit, Denizli, Turkey
关键词
cell separators; peripheral blood progenitor cells; autologous; apheresis;
D O I
10.1016/j.transci.2006.10.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peripheral blood progenitor cells (PBPC) are commonly used as a stein cell source for autologous transplantation. This study was undertaken to evaluate blood cell separators with respect to separation results and content of the harvest. Forty autologous PBPC collections in patients with hernatological malignancies were performed with either the Amicus or the COM.TEC cell separators. The median product volume was lower with the Amicus compared to the COM.TEC (125 mL vs. 300 mL; p < 0.001). There was no statistically significant difference in the median number of CD34+ cell/ kg in product between the Amicus and the COM.TEC (3.0 x 10(6) vs. 4.1 X 10(6); P = 0.129). There was a statistically higher mean volume of ACD used in collections on the Amicus compared to the COM.TEC (1040 241 mL vs. 868 + 176 mL; p = 0.019). There was a statistical difference in platelet (PLT) contamination of the products between the Amicus and the COM.TEC (0.3 x 10(11) vs. 1.1 x 10(11); p < 0.001). The median % decrease in PB PLT count was statistically higher in the COM.TEC compared to the Amicus instruments (18.5% vs. 9.50/0; p = 0.028). In conclusion, both instruments collected PBPCs efficiently. However, Amicus has the advantage of lower PLT contamination in the product, and less decrease in PB platelet count with lower product volume in autologous setting. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 50 条
  • [31] Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial
    N Schmitz
    P Ljungman
    C Cordonnier
    C Kempf
    W Linkesch
    A Alegre
    C Solano
    B Simonsson
    R Sonnen
    V Diehl
    T Fischer
    D Caballero
    T Littlewood
    R Noppeney
    P Schafhausen
    L Jost
    F Delabarre
    R Marcus
    Bone Marrow Transplantation, 2004, 34 : 955 - 962
  • [32] Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial
    Schmitz, N
    Ljungman, P
    Cordonnier, C
    Kempf, C
    Linkesch, W
    Alegre, A
    Solano, C
    Simonsson, B
    Sonnen, R
    Diehl, V
    Fischer, T
    Caballero, D
    Littlewood, T
    Noppeney, R
    Schafhausen, P
    Jost, L
    Delabarre, F
    Marcus, R
    BONE MARROW TRANSPLANTATION, 2004, 34 (11) : 955 - 962
  • [33] Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience
    Castagnola, C
    Alessandrino, EP
    Lunghi, M
    Bernasconi, P
    Della Porta, M
    Mangiacavalli, S
    Colombo, A
    Corso, A
    Pagnucco, G
    Lazzarino, M
    Bernasconi, C
    ANNALS OF HEMATOLOGY, 2001, 80 (05) : 267 - 271
  • [34] Comparison of peripheral blood automated hematopoietic progenitor cell count and flow cytometric CD34+cell count
    Hagenkoetter, Mischa
    Mika, Thomas
    Ladigan-Badura, Swetlana
    Schork, Karin
    Eisenacher, Martin
    Schroers, Roland
    Baraniskin, Alexander
    JOURNAL OF CLINICAL APHERESIS, 2024, 39 (03)
  • [35] COMPARISON OF COBE SPECTRA AND HEMONETICS MCS-3P CELL SEPARATORS FOR PERIPHERAL-BLOOD STEM-CELL HARVESTING
    MEHTA, J
    POWLES, R
    CABRAL, S
    SHEPHERD, V
    SINGHAL, S
    MORILLA, R
    TRELEAVEN, J
    BONE MARROW TRANSPLANTATION, 1995, 16 (05) : 707 - 709
  • [36] Large volume leukapheresis in small children: safety profile and variables affecting peripheral blood progenitor cell collection
    J Sevilla
    M González-Vicent
    L Madero
    F García-Sánchez
    M Angel Diaz
    Bone Marrow Transplantation, 2003, 31 : 263 - 267
  • [37] Procedure-related complications and adverse events associated with pediatric autologous peripheral blood stem cell collection
    Cooling, Laura
    Hoffmann, Sandra
    Webb, Dawn
    Meade, Micheal
    Yamada, Chisa
    Davenport, Robertson
    Yanik, Gregory
    JOURNAL OF CLINICAL APHERESIS, 2017, 32 (01) : 35 - 48
  • [38] High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization:: an indication for patients at risk for low mobilization
    Tarella, C
    Di Nicola, M
    Caracciolo, D
    Zallio, F
    Cuttica, A
    Omedè, P
    Bondesan, P
    Magni, M
    Matteucci, P
    Gallamini, A
    Pileri, A
    Gianni, AM
    BONE MARROW TRANSPLANTATION, 2002, 30 (11) : 725 - 732
  • [39] Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines
    Passeri, Cecilia
    Iuliani, Ornella
    Di Ianni, Mauro
    Sorrentino, Carlo
    Giancola, Raffaella
    Abbruzzese, Luciano
    Dallavalle, Franco M.
    Gattillo, Salvatore
    Mariano, Maria T.
    Martino, Massimo
    Ostuni, Angelo
    Savignano, Chiara
    Santoleri, Luca
    Tison, Tiziana
    Vacca, Michele
    Accorsi, Patrizia
    BLOOD TRANSFUSION, 2023, 21 (01) : 37 - 41
  • [40] Correlation between peripheral blood automated hematopoietic progenitor cell counts and flow cytometric CD34+ cell counts differs according to diagnosis in patients undergoing autologous peripheral blood stem cell transplantation
    Kim, Sang-Mi
    Kim, Hyun-Young
    Kim, Seok Jin
    Jang, Jun Ho
    Kim, Kihyun
    Kim, Won Seog
    Jung, Chul Won
    Cho, Duck
    Kang, Eun-Suk
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (05) : 737 - 749